Esta web utiliza cookies técnicas, de personalización y de análisis, propias y de terceros, para anónimamente facilitarle la navegación y analizar estadísticas del uso de la web. Obtener más información
Resultados de búsqueda
-
Invertir en el bitcoin
Antón, Miguel; Giné, Mireia; de la Peña, Juan VidalCaso F-968FinanzasTras casi diez meses de confinamientos intermitentes por la pandemia de covid, una gestora de hedge funds de Barcelona recibe una llamada del mayor inversor de un fondo de 480 millones de euros. El fondo, que históricamente ha tenido un gran comportamiento, lleva tres meses muy malos. Contrariado porque sus amigos presumen de no haber perdido ni un céntimo gracias a su exposición a las criptomonedas y la gestora no ha invertido todavía en el bitc...Desde 8,20 €
-
bnc10: An Alternative to Traditional Banking
Antón, Miguel; Giné, Mireia; de la Peña, Juan Vidal; Llorens AlbertCaso F-969-EEconomía, FinanzasNew round of financing for a recently born NeobankDesde 8,20 €
-
HIFU TAOC: Investing in Tech Projects: Introduction to Project Valuation
Antón, Miguel; Giné, Mireia; Eufinger, Christian; Sacchetto, StefanoCaso F-996-EFinanzasThe case delves into the strategic decision-making process at Tel Aviv Oncology Center (TAOC) under the leadership of its new Managing Director, Dr. Lia Abrams. With a vision to establish TAOC as a regional reference center, Dr. Abrams evaluates the adoption of High-Intensity Focused Ultrasound (HIFU) technology, a non-invasive treatment for tumors in hard-to-operate areas. The case discusses the potential financial benefits of this investment, i...Desde 8,20 €
-
Investing in Bitcoin
Antón, Miguel; Giné, Mireia; de la Peña, Juan VidalCaso F-968-EFinanzasDesde 8,20 €
-
Leadership Development: Perk or Priority? (HBR Case Study and Commentary) (Spanish version)
Kesner, Idalene F.; Burnett, Susan; Morrison, Mike; Tichy, Noel M.; Owens, DavidArtículo HBS-R0305ALiderazgo y Dirección de personasKaren Barton, Zendal Pharmaceuticals' senior vice-president of human resources, was livid when COO Dave Palmer slashed her executive education budget by 75%. Without funding, there could be no in-house leadership development program, which was to be the first step toward a full-blown Zendal University. Palmer was not against bold initiatives, but sales were down 26%, and there was that $300 million debt Zendal took on when it acquired Premier Pha...Desde 8,20 €
-
Leadership Development: Perk or Priority? (HBR Case Study and Commentary)
Kesner, Idalene F.; Burnett, Susan; Morrison, Mike; Tichy, Noel M.; Owens, DavidArtículo HBS-R0305A-ELiderazgo y Dirección de personasKaren Barton, Zendal Pharmaceuticals' senior vice-president of human resources, was livid when COO Dave Palmer slashed her executive education budget by 75%. Without funding, there could be no in-house leadership development program, which was to be the first step toward a full-blown Zendal University. Palmer was not against bold initiatives, but sales were down 26%, and there was that $300 million debt Zendal took on when it acquired Premier Pha...Desde 8,20 €